Yao-Hwa Glass Management Commission

The Yao-Hwa Glass Management Commission is a strategic investment entity under the jurisdiction of the Ministry of Economic Affairs (MOEA) in Taiwan. Originally established to manage the assets of the state-owned Yao-Hwa Glass Company, it has transitioned into a powerful government-linked venture capital fund. The commission plays a critical role in Taiwan's industrial policy by providing capital to high-tech sectors, most notably as a founding investor in TSMC. In the life sciences sector, it serves as a major institutional investor, holding significant equity in prominent Taiwanese biotech firms such as TaiMed Biologics and United Biopharma. The entity functions as a vehicle for the Taiwanese government to foster innovation and support the commercialization of domestic biopharmaceutical research.